How Should Investors Think About the Delta Variant?

Audio Description

Bernstein Research's Biopharma Analyst, Ronny Gal, joins our Co-Head of Investment Strategies, Beata Kirr, to discuss the latest Covid trends. What do you need to know about the delta variant, vaccines, the road to herd immunity, and how the science behind the Covid vaccine is likely to keep changing our lives in the future?

Matthew D. Palazzolo
Senior Investment Strategist—National Director, Investment Insights
Beata Kirr
Co-Head—Investment Strategies

The information presented and opinions expressed are solely the views of the podcast host commentator and their guest speaker(s). AllianceBernstein L.P. or its affiliates makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this podcast. This podcast is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor’s personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer or solicitation for the purchase or sale of any financial instrument, product or service sponsored by AllianceBernstein or its affiliates.

Related Insights

Update browser for the best experience

We may not support your browser anymore. For the best experience, we recommend using the most recent version, or one of our supported browsers.